From: A comparative study of the sarcopenia screening in older patients with interstitial lung disease
 | Overall (n = 78) | AWGS 2019 criteria classification | ||
---|---|---|---|---|
Sarcopenia (n = 25) | Non-sarcopenia (n = 53) | P value | ||
Age, years | 71 (67–77) | 72 (68–77) | 71 (67–82) | 0.499 |
Sex male, % | 51 (65) | 16 (64) | 35 (66) | 1.00 |
BMI, kg/m2 | 24 (20–26) | 23 (20–28) | 24 (22–26) | 0.855 |
Diagnosis, IIPs/other ILDs | 49/29 | 15/10 | 34/19 | 0.804 |
Duration from diagnosis, months | 3 (1–16) | 2 (1–12) | 6 (1–23) | 0.227 |
Corticosteroid, % | 12 (15) | 6 (24) | 6 (11) | 0.184 |
Antifibrotic drugs, % | 16 (21) | 4 (16) | 12 (23) | 0.564 |
Long-term oxygen therapy, % | 11 (14) | 5 (20) | 6 (11) | 0.316 |
ILD-GAP score, point | 3 (2–4) | 3 (2–4) | 3 (2–4) | 0.551 |
mMRC dyspnea scale, grade | 2 (1–2) | 2 (1–2) | 1 (1–2) | 0.754 |
PaCO2 at rest, mmHg | 41 (38–46) | 40 (38–44) | 42 (38–51) | 0.417 |
PaO2 at rest, mmHg | 80 (63–91) | 86 (73–94) | 75 (61–91) | 0.219 |
FVC, % | 85 (68–97) | 85 (63–93) | 85 (72–98) | 0.316 |
FEV1, %pred | 90 (75–101) | 90 (69–103) | 90 (77–101) | 0.863 |
FEV1/FVC, % | 78 (72–86) | 80 (72–87) | 78 (72–85) | 0.514 |
DLCO, % | 64 (45–80) | 70 (45–83) | 60 (45–80) | 0.271 |
KL-6, U/ml | 715 (451–1165) | 662 (474–1168) | 740 (407–1155) | 0.768 |
HF, kgf | 26 (20–33) | 23 (19–33) | 27 (22–34) | 0.167 |
QF, kgf | 28 (19–35) | 23 (16–33) | 29 (20–36) | 0.169 |
Calf circumference, cm | 33 (30–35) | 33 (30–37) | 34 (30–35) | 0.996 |
SMI, kg/m2 | 7 (6–7) | 7 (5–7) | 7 (6–8) | 0.201 |
SPPB, point | 11 (11–12) | 12 (11–12) | 12 (11–12) | 0.912 |
SARC-F, point | 1 (0–2) | 1 (0–4) | 1 (0–2) | 0.486 |
SARC-CalF, point | 2 (0–11) | 11 (0–12) | 1 (0–11) | 0.171 |
6MWD, m | 424 (355–500) | 392 (308–509) | 442 (371–500) | 0.317 |
ADL score | 6 (6–6) | 6 (6–6) | 6 (6–6) | 0.204 |
K-BILD, point | 54 (47–64) | 53 (44–68) | 54 (48–62) | 0.684 |
Psychological symptoms | 51 (43–63) | 49 (43–67) | 52 (42–60) | 0.720 |
Breathlessness and activities | 44 (34–53) | 40 (31–55) | 46 (37–53) | 0.232 |
Chest symptoms | 73 (64–85) | 73 (47–85) | 73 (64–85) | 0.779 |